Jobs

  • German biopharmaceutical company Revotar has announced that its Bimosiamose inhalation solution for the treatment of COPD met its primary endpoint in a Phase 2 study involving more than 75 patients with moderate-to-severe COPD. Bimosiamose is… Read more . . .

  • Freeman Technology will offer the new Graphical User Interface (GUI) for its FT4 powder rheometer instrument with all new instruments, and it will be available as a free upgrade for current owners. The FT4 provides… Read more . . .

  • The COPD Foundation has announced that COPD: Journal of Chronic Obstructive Pulmonary Disease will be its official journal. According to John W Walsh, President of the COPD Foundation, “COPD: Journal of Chronic Obstructive Pulmonary Disease,… Read more . . .

  • Biopharmaceutical company Insmed Incorporated has announced that its shareholders have approved a one-for-ten reverse stock split and the conversion of its Series B preferred stock into common stock. Insmed acquired Transave and its Arikace inhaled… Read more . . .

  • Submit poster and paper abstracts by May 27, 2011 to info@apsgb.org. See abstract guidelines (link opens Word document). Five £100 prizes will be awarded. Read more . . .

  • Submit call for papers form to hexagon@hexagon.dk or fax to +45 33 13 38 59. Read more . . .

  • Anyone interested in presenting should contact andrea.jandrea.james@management-forum.co.uk Read more . . .

  • Mangrove Partners, which holds approximately %5.7 of the outstanding shares of CPEX Pharmaceuticals, has announced that it will oppose the merger of CPEX with FCB, a wholly-owned subsidiary of Footstar Corporation. The merger was announced… Read more . . .

  • Savara Pharmaceuticals is seeking a high energy individual to fill a laboratory-based role in its formulation and analytical development laboratories.  The successful candidate should be comfortable working in a start-up company and have experience supporting… Read more . . .

  • 3M Drug Delivery Systems Division partners with pharmaceutical and biotech companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with regulatory… Read more . . .

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK